Cormorant Asset Management as of June 30, 2016
Portfolio Holdings for Cormorant Asset Management
Cormorant Asset Management holds 84 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alder Biopharmaceuticals | 6.0 | $42M | 1.7M | 24.97 | |
| Nevro (NVRO) | 5.1 | $36M | 491k | 73.76 | |
| Heron Therapeutics (HRTX) | 4.5 | $32M | 1.8M | 18.05 | |
| Tesaro | 4.3 | $31M | 363k | 84.05 | |
| Nektar Therapeutics (NKTR) | 4.1 | $29M | 2.0M | 14.23 | |
| Minerva Neurosciences | 4.0 | $29M | 2.8M | 10.21 | |
| Theravance Biopharma (TBPH) | 3.6 | $25M | 1.1M | 22.69 | |
| Sage Therapeutics (SAGE) | 3.1 | $22M | 730k | 30.13 | |
| Eagle Pharmaceuticals (EGRX) | 2.8 | $20M | 506k | 38.79 | |
| Macrogenics (MGNX) | 2.7 | $19M | 708k | 26.99 | |
| Vitae Pharmaceuticals | 2.7 | $19M | 1.8M | 10.79 | |
| Galapagos Nv- (GLPG) | 2.6 | $18M | 334k | 54.92 | |
| Neurocrine Biosciences (NBIX) | 2.6 | $18M | 398k | 45.45 | |
| Omeros Corporation (OMER) | 2.5 | $18M | 1.7M | 10.52 | |
| Aclaris Therapeutics (ACRS) | 2.4 | $17M | 901k | 18.47 | |
| Proteostasis Therapeutics In | 2.3 | $16M | 1.4M | 12.13 | |
| Clearside Biomedical (CLSD) | 2.0 | $14M | 2.0M | 7.01 | |
| Cellectis S A (CLLS) | 1.9 | $13M | 498k | 26.59 | |
| Ardelyx (ARDX) | 1.9 | $13M | 1.5M | 8.73 | |
| China Biologic Products | 1.7 | $12M | 113k | 106.32 | |
| Quotient | 1.7 | $12M | 1.5M | 7.75 | |
| Sorrento Therapeutics (SRNEQ) | 1.7 | $12M | 2.1M | 5.60 | |
| Novavax | 1.7 | $12M | 1.6M | 7.27 | |
| Alnylam Pharmaceuticals (ALNY) | 1.6 | $11M | 200k | 55.49 | |
| Coherus Biosciences (CHRS) | 1.4 | $9.7M | 576k | 16.89 | |
| Portola Pharmaceuticals | 1.3 | $9.3M | 396k | 23.60 | |
| Myokardia | 1.3 | $9.4M | 758k | 12.40 | |
| Dynavax Technologies (DVAX) | 1.3 | $9.3M | 635k | 14.58 | |
| Relypsa | 1.2 | $8.3M | 450k | 18.50 | |
| Wave Life Sciences (WVE) | 1.2 | $8.2M | 394k | 20.69 | |
| Sangamo Biosciences (SGMO) | 1.1 | $8.1M | 1.4M | 5.79 | |
| Dex (DXCM) | 1.1 | $7.9M | 100k | 79.33 | |
| Achillion Pharmaceuticals | 1.1 | $7.8M | 1.0M | 7.80 | |
| Inc Resh Hldgs Inc cl a | 1.1 | $7.6M | 200k | 38.13 | |
| Seres Therapeutics (MCRB) | 1.0 | $7.4M | 253k | 29.05 | |
| Advaxis | 0.9 | $6.6M | 810k | 8.09 | |
| Agenus (AGEN) | 0.9 | $6.4M | 1.6M | 4.05 | |
| Recro Pharma (SCTL) | 0.9 | $6.2M | 778k | 7.95 | |
| Forward Pharma A/s | 0.9 | $6.2M | 339k | 18.17 | |
| Corbus Pharmaceuticals Hldgs | 0.8 | $6.0M | 2.0M | 2.99 | |
| Ultragenyx Pharmaceutical (RARE) | 0.8 | $5.4M | 111k | 48.91 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.8 | $5.4M | 456k | 11.85 | |
| Pfenex | 0.8 | $5.3M | 633k | 8.37 | |
| Dermira | 0.7 | $5.0M | 172k | 29.25 | |
| Acceleron Pharma | 0.6 | $4.3M | 128k | 33.98 | |
| Agile Therapeutics | 0.6 | $4.3M | 564k | 7.61 | |
| Atara Biotherapeutics (ATRA) | 0.6 | $4.2M | 187k | 22.51 | |
| Lion Biotechnologies | 0.6 | $4.1M | 506k | 8.10 | |
| Cytomx Therapeutics (CTMX) | 0.5 | $3.8M | 372k | 10.21 | |
| Intec Pharma | 0.5 | $3.7M | 810k | 4.60 | |
| Immune Design | 0.5 | $3.5M | 433k | 8.16 | |
| Oncobiologics | 0.5 | $3.5M | 1.0M | 3.40 | |
| Zynerba Pharmaceuticals | 0.5 | $3.3M | 481k | 6.85 | |
| Corvus Pharmaceuticals (CRVS) | 0.4 | $3.1M | 214k | 14.26 | |
| Contrafect | 0.3 | $2.4M | 841k | 2.89 | |
| Aptose Biosciences | 0.3 | $2.4M | 991k | 2.44 | |
| Lipocine | 0.3 | $2.3M | 751k | 3.04 | |
| Agios Pharmaceuticals (AGIO) | 0.3 | $2.1M | 50k | 41.90 | |
| Glycomimetics (GLYC) | 0.3 | $2.1M | 287k | 7.27 | |
| Syndax Pharmaceuticals (SNDX) | 0.3 | $2.1M | 214k | 9.85 | |
| Blueprint Medicines (BPMC) | 0.3 | $2.0M | 101k | 20.25 | |
| Celyad Sa | 0.3 | $1.9M | 76k | 24.97 | |
| Curis | 0.3 | $1.8M | 1.2M | 1.56 | |
| Epizyme | 0.2 | $1.6M | 160k | 10.24 | |
| Regenxbio Inc equity us cm (RGNX) | 0.2 | $1.3M | 157k | 8.00 | |
| AVEO Pharmaceuticals | 0.1 | $1.0M | 1.1M | 0.96 | |
| Aquinox Pharmaceuticals | 0.1 | $1.0M | 152k | 6.62 | |
| Amicus Therapeutics (FOLD) | 0.1 | $829k | 152k | 5.46 | |
| Provectus Biopharmaceuticals I (PVCT) | 0.1 | $824k | 2.2M | 0.37 | |
| Ascendis Pharma A S (ASND) | 0.1 | $826k | 62k | 13.27 | |
| Tetralogic Pharmaceuticals c note 8.000% 6/1 | 0.1 | $850k | 5.0M | 0.17 | |
| Genvec | 0.1 | $679k | 1.2M | 0.57 | |
| Threshold Pharmaceuticals | 0.1 | $648k | 1.0M | 0.64 | |
| Htg Molecular Diagnostics | 0.1 | $529k | 204k | 2.60 | |
| Nanostring Technologies (NSTGQ) | 0.1 | $510k | 41k | 12.60 | |
| Neos Therapeutics | 0.1 | $470k | 51k | 9.29 | |
| Provectus Biopharmaceuticals *w exp 06/24/202 | 0.1 | $418k | 2.2M | 0.19 | |
| Invuity | 0.1 | $326k | 34k | 9.53 | |
| Applied Genetic Technol Corp C | 0.0 | $245k | 17k | 14.14 | |
| Adaptimmune Therapeutics (ADAP) | 0.0 | $206k | 25k | 8.14 | |
| Cellectar Biosciences | 0.0 | $185k | 54k | 3.45 | |
| Oncobiologics Inc *w exp 02/18/201 | 0.0 | $192k | 417k | 0.46 | |
| Oncobiologics Inc *w exp 05/18/201 | 0.0 | $188k | 417k | 0.45 | |
| Cellectar Biosciences Equity Warrants *w | 0.0 | $29k | 53k | 0.55 |
